Fourteen years of tobacco control law in Spain. Current situation and proposals
Abstract
Spain has made progress in tobacco control policies, highlighting the prohibition of tobacco consumption in closed public spaces. A continued decrease in the proportion of smokers is observed. Exposure to environmental tobacco smoke has decreased in entertainment venues, with a reduction of environmental nicotine and particulate levels over 90%, without negative impact at home. There are reductions in hospital admissions and in mortality from heart attack, decrease in hospitalizations for chronic lung disease and asthma, and decrease in the risk of prematurity and low birth weight. We must advance in: plain packaging, advertising campaigns to prevent consumption, equalize the price of different tobacco products, regulate electronic cigarettes in public places, consider new smoke-free spaces where minors and other vulnerable groups may be exposed, expand aid for cessation and promote health professionals training.
España ha avanzado en políticas de control del tabaquismo, destacando la prohibición del consumo de tabaco en espacios públicos cerrados. Se observa un descenso continuado en la proporción de fumadores. La exposición al humo ambiental de tabaco ha disminuido en lugares de ocio, con reducción de niveles de nicotina ambiental y partículas mayor del 90%, sin impacto negativo en el hogar. Hay reducciones en los ingresos hospitalarios y en la mortalidad por infarto cardiaco, descenso de las hospitalizaciones por enfermedad pulmonar crónica y asma y disminución del riesgo…
Read the paper
Related studies
- Tobacco and COPD: presenting the World Health Organization (WHO) Tobacco Knowledge Summary
- Comparative effects of e-cigarette smoking on periodontal status, salivary pH, and cotinine levels
- Association between exposure to environmental pollutants and increased oral health risks, a comprehensive review
- Influence of gestational window on offspring vascular health in rodents with in utero exposure to electronic cigarettes
- Natural products as kinase inhibitors in lung cancer: molecular mechanisms, therapeutic potential, and clinical trials
- Nicotine in electronic cigarettes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.